Physician step prescription and monitoring to improve ARTERial health (SMARTER): A randomized controlled trial in patients with type 2 diabetes and hypertension

Kaberi Dasgupta, Ellen Rosenberg, Lawrence Joseph, Alexandra B Cooke, Luc Trudeau, Simon L Bacon, Deborah Chan, Mark Sherman, Rémi Rabasa-Lhoret, Stella S Daskalopoulou, SMARTER Trial Group, Kaberi Dasgupta, Ellen Rosenberg, Lawrence Joseph, Alexandra B Cooke, Luc Trudeau, Simon L Bacon, Deborah Chan, Mark Sherman, Rémi Rabasa-Lhoret, Stella S Daskalopoulou, SMARTER Trial Group

Abstract

Aims: There are few proven strategies to enhance physical activity and cardiometabolic profiles in patients with type 2 diabetes and hypertension. We examined the effects of physician-delivered step count prescriptions and monitoring.

Methods: Participants randomized to the active arm were provided with pedometers and they recorded step counts. Over a 1-year period, their physicians reviewed their records and provided a written step count prescription at each clinic visit. The overall goal was a 3000 steps/day increase over 1 year (individualized rate of increase). Control arm participants were advised to engage in physical activity 30 to 60 min/day. We evaluated effects on step counts, carotid femoral pulse wave velocity (cfPWV, primary) and other cardiometabolic indicators including haemoglobin A1c in diabetes (henceforth abbreviated as A1c) and Homeostasis Model Assessment-Insulin Resistance (HOMA-IR) in participants not receiving insulin therapy.

Results: A total of 79% completed final evaluations (275/347; mean age, 60 years; SD, 11). Over 66% of participants had type 2 diabetes and over 90% had hypertension. There was a net 20% increase in steps/day in active vs control arm participants (1190; 95% CI, 550-1840). Changes in cfPWV were inconclusive; active vs control arm participants with type 2 diabetes experienced a decrease in A1c (-0.38%; 95% CI, -0.69 to -0.06). HOMA-IR also declined in the active arm vs the control arm (ie, assessed in all participants not treated with insulin; -0.96; 95% CI, -1.72 to -0.21).

Conclusions: A simple physician-delivered step count prescription strategy incorporated into routine clinical practice led to a net 20% increase in step counts; however, this was below the 3000 steps/day targeted increment. While conclusive effects on cfPWV were not observed, there were improvements in both A1c and insulin sensitivity. Future studies will evaluate an amplified intervention to increase impact.

Keywords: arterial stiffness; carotid femoral pulse wave velocity; diabetes; hypertension; pedometer; physical activity; step counter.

© 2017 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.

Figures

Figure 1
Figure 1
Participant flow. * angina (1), chronic obstructive pulmonary disease (6), inflammatory arthritis (2), cancer (4), renal disease (1), liver disease (1), depression (1), urinary impairment (2). † PVCs, irregular sinus rhythm.

References

    1. Gregg EW, Gerzoff RB, Caspersen CJ, Williamson DF, Narayan KM. Relationship of walking to mortality among US adults with diabetes. Arch Intern Med. 2003;163:1440‐1447.
    1. Hu FB, Stampfer MJ, Solomon C, et al. Physical activity and risk for cardiovascular events in diabetic women. Ann Intern Med. 2001;134:96‐105.
    1. Smith TC, Wingard DL, Smith B, Kritz‐Silverstein D, Barrett‐Connor E. Walking decreased risk of cardiovascular disease mortality in older adults with diabetes. J Clin Epidemiol. 2007;60:309‐317.
    1. Yates T, Haffner SM, Schulte PJ, et al. Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis. Lancet. 2014;383:1059‐1066.
    1. Bravata DM, Smith‐Spangler C, Sundaram V, et al. Using pedometers to increase physical activity and improve health: a systematic review. JAMA. 2007;298:2296‐2304.
    1. Qiu S, Cai X, Chen X, Yang B, Sun Z. Step counter use in type 2 diabetes: a meta‐analysis of randomized controlled trials. BMC Med. 2014;12:36.
    1. Tudor‐Locke C, Bell RC, Myers AM, et al. Controlled outcome evaluation of the First Step Program: a daily physical activity intervention for individuals with type II diabetes. Int J Obes Relat Metab Disord. 2004;28:113‐119.
    1. Douglas F, Torrance N, van Teijlingen E, Meloni S, Kerr A. Primary care staff's views and experiences related to routinely advising patients about physical activity. A questionnaire survey. BMC Public Health. 2006;6:138.
    1. Campkin L, Doyle‐Baker PK. Exercise counselling and use of exercise professionals by physicians: Findings from a scoping review. Alberta Centre for Active Living 2015; July 8, 2015. . Accessed December 12, 2016.
    1. Patel A, Schofield GM, Kolt GS, Keogh JW. General practitioners’ views and experiences of counselling for physical activity through the New Zealand Green Prescription program. BMC Fam Pract. 2011;12:119.
    1. Mitchell GF, Hwang SJ, Vasan RS, et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation. 2010;121:505‐511.
    1. Mattace‐Raso FU, van der Cammen TJ, Hofman A, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006;113:657‐663.
    1. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all‐cause mortality with arterial stiffness: a systematic review and meta‐analysis. J Am Coll Cardiol. 2010;55:1318‐1327.
    1. Dasgupta K, Rosenberg E, Daskalopoulou SS. Step Monitoring to improve ARTERial health (SMARTER) through step count prescription in type 2 diabetes and hypertension: trial design and methods. Cardiovasc Diabetol. 2014;13:7.
    1. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346:793‐801.
    1. Warburton DE, Nicol CW, Bredin SS. Health benefits of physical activity: the evidence. CMAJ. 2006;174:801‐809.
    1. Townsend RR, Wilkinson IB, Schiffrin EL, et al. Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association. Hypertension. 2015;66:698‐722.
    1. Laurent S, Cockcroft J, Van BL, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588‐2605.
    1. Doonan RJ, Scheffler P, Yu A, et al. Altered arterial stiffness and subendocardial viability ratio in young healthy light smokers after acute exercise. PLoS One. 2011;6:e26151.
    1. Mora S, Cook N, Buring JE, Ridker PM, Lee IM. Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation. 2007;116:2110‐2118.
    1. Bowles DK, Laughlin MH. Mechanism of beneficial effects of physical activity on atherosclerosis and coronary heart disease. J Appl Physiol. 2011;111(1):308‐310. doi:10.1152/japplphysiol.00634.2011.
    1. Daskalopoulou SS, Khan NA, Quinn RR, et al. The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol. 2012;28:270‐287.
    1. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta‐cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412‐419.
    1. Marshall SJ, Levy SS, Tudor‐Locke CE, et al. Translating physical activity recommendations into a pedometer‐based step goal: 3000 steps in 30 minutes. Am J Prev Med. 2009;36:410‐415.
    1. Stevens RJ, Coleman RL, Adler AI, Stratton IM, Matthews DR, Holman RR. Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66. Diabetes Care. 2004;27:201‐207.
    1. Bonora E, Formentini G, Calcaterra F, et al. HOMA‐estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care. 2002;25:1135‐1141.
    1. Vaes AW, Cheung A, Atakhorrami M, et al. Effect of ‘activity monitor‐based’ counseling on physical activity and health‐related outcomes in patients with chronic diseases: a systematic review and meta‐analysis. Ann Med. 2013;45:397‐412.
    1. De Greef K, Deforche B, Tudor‐Locke C, De Bourdeaudhuij I. Increasing physical activity in Belgian type 2 diabetes patients: a three‐arm randomized controlled trial. Int J Behav Med. 2011;18:188‐198.
    1. Wen CP, Wai JP, Tsai MK, et al. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet. 2011;378:1244‐1253.
    1. Casey D, De Civita M, Dasgupta K. Understanding physical activity facilitators and barriers during and following a supervised exercise programme in Type 2 diabetes: a qualitative study. Diabet Med. 2010;27:79‐84.
    1. Kirkman MS, Weinberger M, Landsman PB, et al. A telephone‐delivered intervention for patients with NIDDM. Effect on coronary risk factors. Diabetes Care. 1994;17:840‐846.
    1. Foster G, Taylor SJ, Eldridge SE, Ramsay J, Griffiths CJ. Self‐management education programmes by lay leaders for people with chronic conditions. Cochrane Database Syst Rev. 2007;4:CD005108.
    1. Arambepola C, Ricci‐Cabello I, Manikavasagam P, Roberts N, French DP, Farmer A. The impact of automated brief messages promoting lifestyle changes delivered via mobile devices to people with Type 2 diabetes: a systematic literature review and meta‐analysis of controlled trials. J Med Internet Res. 2016;18:e86.
    1. Madden KM, Lockhart C, Cuff D, Potter TF, Meneilly GS. Short‐term aerobic exercise reduces arterial stiffness in older adults with type 2 diabetes, hypertension, and hypercholesterolemia. Diabetes Care. 2009;32:1531‐1535.
    1. Ashor AW, Lara J, Siervo M, Celis‐Morales C, Mathers JC. Effects of exercise modalities on arterial stiffness and wave reflection: a systematic review and meta‐analysis of randomized controlled trials. PLoS One. 2014;9:e110034.
    1. Jennersjo P, Ludvigsson J, Lanne T, Nystrom FH, Ostgren CJ. Pedometer‐determined physical activity level and change in arterial stiffness in Type 2 diabetes over 4 years. Diabet Med. 2012;29:1119–1125.
    1. Umpierre D, Ribeiro PA, Kramer CK, et al. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta‐analysis. JAMA. 2011;305:1790‐1799.
    1. Boule N, Kenny G, Haddad E, Wells G, Sigal R. Meta‐analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus. Diabetologia. 2003;46:1071‐1081.
    1. Snowling NJ, Hopkins WG. Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta‐analysis. Diabetes Care. 2006;29:2518‐2527.
    1. Thomas DE, Elliott EJ, Naughton GA. Exercise for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2006;3:CD002968.
    1. Bell GJ, Harber V, Murray T, Courneya KS, Rodgers W. A comparison of fitness training to a pedometer‐based walking program matched for total energy cost. J Phys Act Health. 2010;7:203‐213.
    1. Hesse BW, Nelson DE, Kreps GL, et al. Trust and sources of health information: the impact of the Internet and its implications for health care providers: findings from the first Health Information National Trends Survey. Arch Intern Med. 2005;165:2618‐2624.
    1. Kao AC, Green DC, Davis NA, Koplan JP, Cleary PD. Patients’ trust in their physicians: effects of choice, continuity, and payment method. J Gen Intern Med. 1998;13:681‐686.
    1. Teoh H, Despres JP, Dufour R, et al. A comparison of the assessment and management of cardiometabolic risk in patients with and without type 2 diabetes mellitus in Canadian primary care. Diabetes Obes Metab. 2013;15:1093‐1100.
    1. Vuori IM, Lavie CJ, Blair SN. Physical activity promotion in the health care system. Mayo Clin Proc. 2013;88:1446‐1461.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅